NIH-funded research R01 grant

Understanding T cell roles in Frontotemporal dementia

Official title: Identifying T cell determinants of heritable Frontotemporal dementia

Funded at Case Western Reserve University · NIH-11055376 · Data updated 2026-11-12

This study is looking at how certain immune cells called T cells might play a role in Frontotemporal dementia and Alzheimer's disease, especially for people with a specific genetic change, and it hopes to find ways to help these immune cells work better to improve health outcomes for patients.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCase Western Reserve University
NIH-funded
Lab location1 site (Cleveland, United States)
Project startApril 1, 2024
Project endMarch 31, 2029
Funding year2025
Award (this year)$631,756
NIH project number5R01AG085316-02
Project IDNIH-11055376 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with Frontotemporal dementia or those carrying the C9ORF72 mutation.

Less likely to help

Patients with other forms of dementia not related to Frontotemporal dementia or the C9ORF72 mutation may not benefit from this research.

What this research studies

This research investigates how T cell dysfunction and the balance of T cell subsets contribute to Frontotemporal dementia (FTD) and Alzheimer's disease. The study aims to explore the interaction between environmental signals, such as those from the gut microbiome, and genetic factors that affect T cell function and disease progression. By focusing on the common C9ORF72 mutation associated with FTD, the research seeks to identify potential strategies to stabilize beneficial T regulatory cells and reduce harmful pro-inflammatory cells, which could improve patient outcomes.

Why it matters

Potential benefit: If successful, this research could lead to new preventative strategies and treatments for Frontotemporal dementia and related disorders.

How similar studies have gone: Other research has shown promising results in understanding T cell roles in neurodegenerative diseases, suggesting that this approach may yield valuable insights.

Where this research is happening

  • Case Western Reserve University
    Cleveland, United States
    Active

Researchers

  • Principal investigator: Burberry, Aaron — Case Western Reserve University
  • Study coordinator: Burberry, Aaron

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.